[Effect of TSC2 gene expression downregulation by lentivirus induced RNA interference on U937 cell line and its

Z F Xu1, H X Liu, Y H Tan

  • 1Department of Hematology, the Second Hospital of Shanxi Medical University, Shanxi Key Laboratory of Molecular Diagnosis and Treatment of Blood Diseases, Taiyuan 030001, China.

Insights

Down-regulating the TSC2 gene in U937 leukemia cells significantly increased cell proliferation and colony formation. This occurred through enhanced mTOR pathway activity, highlighting a key mechanism in leukemia progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • The tuberous sclerosis complex 2 (TSC2) gene plays a role in cell growth regulation.
  • Dysregulation of TSC2 is implicated in various cancers, including leukemia.
  • Understanding TSC2's impact on leukemia cell biology is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the biological effects of down-regulated TSC2 gene expression in U937 leukemia cells.
  • To determine the influence of TSC2 on cell proliferation, apoptosis, and differentiation.
  • To elucidate the role of the mTOR pathway in TSC2-mediated leukemia cell behavior.

Main Methods:

  • Lentivirus-induced RNA interference was used to down-regulate TSC2 expression in U937 cells.
  • Cell proliferation and colony formation were assessed using CCK-8 and colony formation assays.
  • Flow cytometry was employed to analyze cell cycle distribution, apoptosis, and differentiation.
  • Quantitative real-time PCR (qRT-PCR) and Western blot were used to measure gene and protein expression and kinase activity.

Main Results:

  • Down-regulated TSC2 expression significantly promoted U937 cell proliferation and colony formation.
  • TSC2 down-regulation led to a decrease in G0/G1 phase cells and an increase in S and G2/M phase cells.
  • Apoptosis and differentiation showed no significant changes, while mTOR, 4EBP1, and S6K1 activities increased.
  • Expressions of cyclinD1, c-myc, and PTEN were upregulated, indicating promotion of cell cycle progression.

Conclusions:

  • Downregulation of TSC2 promotes U937 leukemia cell proliferation.
  • The observed proliferation is mediated by the up-regulation of the mTOR signaling pathway.
  • Targeting the TSC2/mTOR axis may offer a potential therapeutic strategy for leukemia.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.0K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.8K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K